Updates
-
The Glittre activities of daily living (ADL) test can help evaluate functional capacity and daily living activities in patients with bronchiectasis, a new study ... Read more
-
Patients, Family and Friends to Take Part in Variety of Rare Disease Day Events Worldwide
Scores of events are afoot worldwide to mark Feb. 28, Rare Disease Day 2019. The activities aim to raise awareness about rare diseases and the millions ... Read more -
Pulmonary Rehabilitation Program May Improve Physical Activity Levels in Adults with Bronchiectasis
A home-based pulmonary rehabilitation program helped to improve the physical activity and overall clinical status of adults with non-cystic fibrosis bronchiectasis, who had low ... Read more -
Traction Bronchiectasis Is a Potential Indicator of Poor Prognosis in Acute Eosinophilic Pneumonia, Study Finds
A retrospective study of acute eosinophilic pneumonia (AEP) patients found that traction bronchiectasis (TBE) may be associated with a poor prognosis and fatal ... Read more -
Independent Review Supports Aqulmiq in Delaying Flares in NCFBE, Report Says
Treatment with Apulmiq (ciprofloxacin) can delay the first acute respiratory episode in non-cystic fibrosis bronchiectasis (NCFBE) patients with chronic Pseudomonas aeruginosa ... Read more
-
Rare Tracheal Infection with Achromobacter in Bronchiectasis Patient Reported in Case Study
A rare infection of the trachea with the bacteria Achromobacter xylosoxidans deteriorated the respiratory function ... -
Statins, Mucolytics May Lower Risk of Exacerbations, Death Among BCO Patients, Study Finds
Statins and mucolytics may lower the risk of acute exacerbations and death among patients ... -
Apulmiq’s Benefits Confirmed in Third-party Evaluation
A third-party evaluation (TPE) confirmed the efficacy of the bronchiectasis treatment candidate Apulmiq found in ... -
Rising Healthcare Costs Strain EU Budgets Even as New Therapies Flourish
Cash-strapped governments across the 28-member European Union are struggling to control runaway healthcare expenditures ... -
Mycobacterium abscessus Gave Rise to Autoimmune Disorder in Bronchiectasis Patient, Report Says
A first case of an autoimmune disorder characterized by inflammation of blood vessels in ... -
Zambon’s Inhalable Antibiotic for Non-CF Bronchiectasis Gets Fast Track, QIDP Status from FDA
The U.S. Food and Drug Administration (FDA) granted Qualified Infectious Diseases Product (QIDP) and ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.